Company Performance Metrics
- Reinhard Mayer: Group CFOPast Role: Nilfisk, Executive Vice President and Chief Financial Officer
- Ville Polojärvi: Senior Innovation Manager
SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. Every day, more than 4,700 people from 65 nations work at SCHOTT Pharma to contribute to global healthcare. The company has 17 manufacturing sites across major pharmaceutical hubs in
Europe, the Americas and Asia.
SCHOTT Pharma maintains a diverse portfolio of injectable drug containment and delivery solutions. These solutions range from prefillable glass and polymer syringes, cartridges, vials and ampoules.
The company has focused on developing innovations for future technologies by: • Creating over 900 patents and technologies developed in-house • Building a state-of-the-art Research and Development Center in Switzerland • Absorbing over 130 professionals focused on Research and Development
Despite being a pharmaceutical manufacturer, SCHOTT Pharma aims to become climate-neutral by 2030. The company commits to this through sustainable development approaches in the society and the environment. Based in Mainz, Germany, it is part of SCHOTT AG that falls under the Carl Zeiss Foundation.
SCHOTT Pharma has over 1700 global customers, 30 of which are the leading pharmaceutical manufacturers of injectable drugs. These customers have generated combined sales of EUR 821 million in the fiscal year 2022.
